Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AM Rx vs AVArx

AM Rx
Graded #490

Lower grade

vs+6
AVArx
Graded #426

Higher grade

The verdict

AVArx takes it — 55.9/100 to 49.9/100.

AVArx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Glendale, California telehealth technology platform connecting patients with prescribers at Arora Health & Aesthetics for GLP-1 and wellness-peptide care, with no prices published before intake.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAM Rx +6
51
45
Dose & formulationAM Rx +25
65
40
Clinical oversightAVArx +36
41
77
Labs & monitoringAVArx +3
49
52
FulfillmentAVArx +27
58
85
Contract termsAVArx +21
20
41
AM Rx · left barAVArx · right bar

The numbers

MetricAM RxAVArx
WeighScore49.9/10055.9/100
GradeCC
Scorecard rank#490#426
Semaglutide$151/mo (quarterly plan, plus a separate fee, compounded)Not disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
AM Rx

Graded #490 · C

Strengths

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • HSA and FSA accepted
  • Video visits available with providers averaging 10+ years' experience
  • Compounded semaglutide from $151/mo on the quarterly plan

Where it loses points

  • Active FTC/DOJ lawsuit over deceptive billing and subscription practices
  • Novo Nordisk false-advertising lawsuit (Aug 2025)
  • Parent company Zealthy holds a BBB D- rating with 2,370+ complaints
  • Trustpilot 2.0/5, with 85% one-star reviews citing billing disputes and unreachable support
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
AVArx

Graded #426 · C

Strengths

  • Publishes exactly which states require a live audio or video visit before a prescription, which almost no competitor discloses
  • Names its prescribing group, Arora Health & Aesthetics, and gives a medical compliance contact
  • Terms state service is available to residents of all 50 states, and the shipping policy matches
  • Dates its own editorial reviews on treatment pages
  • HSA/FSA accepted with receipts provided for reimbursement

Where it loses points

  • No price is published anywhere on the site, on treatment pages or in the intake, so you cannot compare before starting a visit
  • Never states whether its semaglutide and tirzepatide are compounded or brand-name
  • No dispensing pharmacy is named, only licensed pharmacies in our network
  • Cancellation terms are not published, only presented at checkout
  • Prescriptions cannot be returned once dispensed, and the refund policy is otherwise unstated

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard